SIGNORI, EMANUELA
SIGNORI, EMANUELA
FARMACOLOGIA TRASLAZIONALE - IFT
A combined analytical approach reveals novel EXT1/2 gene mutations in a large cohort of Italian multiple osteochondromas patients.
2007 Signori, E; Massi, E; Matera, Mg; Poscente, M; Gravina, C; Falcone, G; Rosa, Ma; Rinaldi, M; Wuyts, W; Seripa, D; Dallapiccola, B; Fazio VM Clinical reference, Groups
A Novel 3D Scaffold for Cell Growth to Assess Electroporation Efficacy
2019 Dettin, Monica; Sieni, Elisabetta; Zamuner, Annj; Marino, Ramona; Sgarbossa, Paolo; Lucibello, Maria; Tosi Anna, Lisa; Keller, Flavio; Campana Luca, Giovanni; Signori, Emanuela
A plasmid family containing two different expression cassettes suitable for immuno-modulation and genetic immunization
1998 Silvia A. Ciafre; Monica Rinaldi; Isabella Vespignani; Paola Parrella; Davide Seripa; Emanuela Signori; Francesco Ria; Maria Giulia Farace;Vito M. Fazio
A somatic mutation in the 5'UTR of BRCA1 gene in sporadic breast cancer causes down-modulation of translation efficiency.
2001 Signori, E; Bagni, C; Papa, S; Primerano, B; Rinaldi, M; Amaldi, F; Fazio, Vm
Adjuvants in vaccines and for immunisation: current trends.
2007 Chiarella, P; Massi, E; De Robertis, M; Signori, E; Fazio, Vm
Alternative BCR/ABL splice variants in Philadelphia chromosome-positive Leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches
2007 Volpe G.; Cignetti A; Panuzzo C.; Kuka M.; Vitaggio K.; Brancaccio M.; Perrone G.; Rinaldi M.; Prato G.; Fava M.; Geuna M.; Pautasso M.; Casnici C.; Signori E.,,; Tonon G.; Tarone G.; Marelli O.; Fazio V.M.,; Saglio G.
Anti-Idiotypic CDR3 Vaccination Against Chronic B-Cell Lymphoma: DNA Vaccine Strategy
2004 Rinaldi, M; Iurescia, S; Fioretti, D; Signori, E; Calì, S; Volpe, G; Casnici, C; Marelli, O; Saglio, G; Tonon, G; Fazio, Vm
Anti-tumor immunity induced by CDR3-based DNA vaccination in a murine B-cell lymphoma model
2008 Rinaldi, M; Fioretti, D; Iurescia, S; Signori, E; Pierimarchi, P; Seripa, D; Tonon, G; Fazio, Vm
Antibodies elicited by naked DNA vaccination against hypervariable VH-CDR3 idiotypic determinants of B-lymphoproliferative disorders specifically react with patients? tumor cells.
2001 Rinaldi M.; Ria F.; Parrella P.; Signori E.; Serra A.; Ciafrè S.A.; Vespignani I.; Lazzari M.; Farace M.G.; Saglio G.; Fazio V.M.
ApoE gene delivery inhibits severe hypercholesterolemia in newborn ApoE-KO mice.
2007 Signori E.; Rinaldi M.; Fioretti D.; Iurescia S.; Seripa D.; Perrone G.; Norata G.D.; Catapano A.L.; Fazio V.M.;
Application of electroporation in DNA vaccination protocols.
2010 Chiarella P.,; Fazio V.M.; Signori E.,
Azoxymethane/Dextran Sodium Sulfate (AOM/DSS) Model of Colorectal Cancer
2024 De Robertis, Mariangela; Signori, Emanuela
BCR/ABL1 fusion transcripts generated from alternative splicing: implications for future targeted therapies in Ph+ leukaemias.
2012 Chiarella, P; Summa, V; De Santis, S; Signori, E; Picardi, E; Pesole, G; Saglio, G; Fazio, Vmpmid
CDR3-targeted DNA vaccines in B-cell lymphoma
2007 Rinaldi, M; Iurescia, S; Fioretti, D; Signori, E; Tonon, G; Fazio, Vm
Clinical applications and immunological aspects of electroporation-based therapies
2021 da Luz, Jcs; Antunes, F; Clavijosalomon, Ma; Signori, E; Tessarollo, Ng; Strauss, Be
Cost-effective and disposable label-free voltammetric immunosensor for sensitive detection of interleukin-6
2022 Cancelliere, R; Di Tinno, A; Di Lellis, Am; Contini, G; Micheli, L; Signori, E
Current understanding and clinical utility of miRNAs regulation of colon cancer stem cells
2018 De Robertis, M; Poeta, Ml; Signori, E; Fazio, Vm
Development of a multigenic plasmid vector for HCV DNA-immunization
1998 Papa S; Rinaldi M; Mangia A; Parrella P; Signori E; Lombardi L;Fazio VM
DNA end binding activity and Ku70/80 heterodimer expression in human colorectal tumor.
2005 Mazzarelli P.; Parrella P.; Seripa D.; Signori E.; Perrone G.; Rabitti C.; Borzomati D.; Gabbrielli A.; Matera M.G.; Gravina C.; Caricato M.; Poeta M.L.; Rinaldi M.; Valeri S.; Coppola R.; Fazio V.M..
DNA vaccination strategies for anti-tumour effective gene therapy protocols
2010 Signori, E; Iurescia, S; Massi, E; Fioretti, D; Chiarella, P; De Robertis, M; Rinaldi, M; Tonon, G; Fazio, Vm
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A combined analytical approach reveals novel EXT1/2 gene mutations in a large cohort of Italian multiple osteochondromas patients. | 1-gen-2007 | Signori, E; Massi, E; Matera, Mg; Poscente, M; Gravina, C; Falcone, G; Rosa, Ma; Rinaldi, M; Wuyts, W; Seripa, D; Dallapiccola, B; Fazio VM Clinical reference, Groups | |
| A Novel 3D Scaffold for Cell Growth to Assess Electroporation Efficacy | 1-gen-2019 | Dettin, Monica; Sieni, Elisabetta; Zamuner, Annj; Marino, Ramona; Sgarbossa, Paolo; Lucibello, Maria; Tosi Anna, Lisa; Keller, Flavio; Campana Luca, Giovanni; Signori, Emanuela | |
| A plasmid family containing two different expression cassettes suitable for immuno-modulation and genetic immunization | 1-gen-1998 | Silvia A. Ciafre; Monica Rinaldi; Isabella Vespignani; Paola Parrella; Davide Seripa; Emanuela Signori; Francesco Ria; Maria Giulia Farace;Vito M. Fazio | |
| A somatic mutation in the 5'UTR of BRCA1 gene in sporadic breast cancer causes down-modulation of translation efficiency. | 1-gen-2001 | Signori, E; Bagni, C; Papa, S; Primerano, B; Rinaldi, M; Amaldi, F; Fazio, Vm | |
| Adjuvants in vaccines and for immunisation: current trends. | 1-gen-2007 | Chiarella, P; Massi, E; De Robertis, M; Signori, E; Fazio, Vm | |
| Alternative BCR/ABL splice variants in Philadelphia chromosome-positive Leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches | 1-gen-2007 | Volpe G.; Cignetti A; Panuzzo C.; Kuka M.; Vitaggio K.; Brancaccio M.; Perrone G.; Rinaldi M.; Prato G.; Fava M.; Geuna M.; Pautasso M.; Casnici C.; Signori E.,,; Tonon G.; Tarone G.; Marelli O.; Fazio V.M.,; Saglio G. | |
| Anti-Idiotypic CDR3 Vaccination Against Chronic B-Cell Lymphoma: DNA Vaccine Strategy | 1-gen-2004 | Rinaldi, M; Iurescia, S; Fioretti, D; Signori, E; Calì, S; Volpe, G; Casnici, C; Marelli, O; Saglio, G; Tonon, G; Fazio, Vm | |
| Anti-tumor immunity induced by CDR3-based DNA vaccination in a murine B-cell lymphoma model | 1-gen-2008 | Rinaldi, M; Fioretti, D; Iurescia, S; Signori, E; Pierimarchi, P; Seripa, D; Tonon, G; Fazio, Vm | |
| Antibodies elicited by naked DNA vaccination against hypervariable VH-CDR3 idiotypic determinants of B-lymphoproliferative disorders specifically react with patients? tumor cells. | 1-gen-2001 | Rinaldi M.; Ria F.; Parrella P.; Signori E.; Serra A.; Ciafrè S.A.; Vespignani I.; Lazzari M.; Farace M.G.; Saglio G.; Fazio V.M. | |
| ApoE gene delivery inhibits severe hypercholesterolemia in newborn ApoE-KO mice. | 1-gen-2007 | Signori E.; Rinaldi M.; Fioretti D.; Iurescia S.; Seripa D.; Perrone G.; Norata G.D.; Catapano A.L.; Fazio V.M.; | |
| Application of electroporation in DNA vaccination protocols. | 1-gen-2010 | Chiarella P.,; Fazio V.M.; Signori E., | |
| Azoxymethane/Dextran Sodium Sulfate (AOM/DSS) Model of Colorectal Cancer | 1-gen-2024 | De Robertis, Mariangela; Signori, Emanuela | |
| BCR/ABL1 fusion transcripts generated from alternative splicing: implications for future targeted therapies in Ph+ leukaemias. | 1-gen-2012 | Chiarella, P; Summa, V; De Santis, S; Signori, E; Picardi, E; Pesole, G; Saglio, G; Fazio, Vmpmid | |
| CDR3-targeted DNA vaccines in B-cell lymphoma | 1-gen-2007 | Rinaldi, M; Iurescia, S; Fioretti, D; Signori, E; Tonon, G; Fazio, Vm | |
| Clinical applications and immunological aspects of electroporation-based therapies | 1-gen-2021 | da Luz, Jcs; Antunes, F; Clavijosalomon, Ma; Signori, E; Tessarollo, Ng; Strauss, Be | |
| Cost-effective and disposable label-free voltammetric immunosensor for sensitive detection of interleukin-6 | 1-gen-2022 | Cancelliere, R; Di Tinno, A; Di Lellis, Am; Contini, G; Micheli, L; Signori, E | |
| Current understanding and clinical utility of miRNAs regulation of colon cancer stem cells | 1-gen-2018 | De Robertis, M; Poeta, Ml; Signori, E; Fazio, Vm | |
| Development of a multigenic plasmid vector for HCV DNA-immunization | 1-gen-1998 | Papa S; Rinaldi M; Mangia A; Parrella P; Signori E; Lombardi L;Fazio VM | |
| DNA end binding activity and Ku70/80 heterodimer expression in human colorectal tumor. | 1-gen-2005 | Mazzarelli P.; Parrella P.; Seripa D.; Signori E.; Perrone G.; Rabitti C.; Borzomati D.; Gabbrielli A.; Matera M.G.; Gravina C.; Caricato M.; Poeta M.L.; Rinaldi M.; Valeri S.; Coppola R.; Fazio V.M.. | |
| DNA vaccination strategies for anti-tumour effective gene therapy protocols | 1-gen-2010 | Signori, E; Iurescia, S; Massi, E; Fioretti, D; Chiarella, P; De Robertis, M; Rinaldi, M; Tonon, G; Fazio, Vm |